The Role of Apoptosis in Gynaecological Malignancies

References

• Kerr JFR, Wyllie AH, Currie AR. Apoptotis: a basic biologic phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–57.
   PubMed Web of Science ®Google Scholar
• Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555–6.
   PubMed Web of Science ®Google Scholar
• Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cell 1986; 44: 817–29.
   PubMed Web of Science ®Google Scholar
• Vaux DL, Cory S, Adams JM. BcI-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440–2.
   PubMed Web of Science ®Google Scholar
• Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macro-molecular synthesis. J Pathol 1984; 142: 67–77.
   PubMed Web of Science ®Google Scholar
• Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 32: 223–54.
   PubMedGoogle Scholar
• Cohen JJ. Programmed cell death in the immune system. Adv Immunol 1991; 50: 55–85.
   PubMed Web of Science ®Google Scholar
• Hockenbery DM, Oltvai ZN, Vi X-M, Milliman CL, Korsmeyer SJ. BcI-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241–51.
   Google Scholar
• Martikainen R Kyprianou N, Isaacs JT. Effect of trans-forming growth factor-B1 on proliferation and death of rat prostatic cells. Endocrinology 1990; 127: 2963–8.
   PubMed Web of Science ®Google Scholar
• Levine B, Huang 0, Isaacs JT, Reed JC, Griffin DE, Hardwick JM. Conversion of lytic to persistent alphavirus infection by the bc1-2 cellular oncogene. Nature 1993; 361: 739–42.
   PubMed Web of Science ®Google Scholar
• Denmeade SR, Isaacs JT. Programmed cell death (apoptosis) and cancer chemotherapy. Cancer Control 1996; 3:303–9.
   Google Scholar
• Collins MKL, Lopez Rivas A. The control of apoptosis in mammalian cells. Trends Biochem Sci 1993; 18: 307–9.
   PubMed Web of Science ®Google Scholar
• >WhiteE. Life, death, and the pursuit of apoptosis. Genes Dev 1996; 10: 1–15.
   Google Scholar
• Bakhshi A, Jensen JP, Goldman P, et al. Cloning the chromosomal break-point of the t(14:18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41: 889–906.
   Web of Science ®Google Scholar
• Tsuijimoto V, Gorham J, Cossman J, Jaffe E, Croce CM. The t(14:18) chromosome translocations involved in B cell neoplasms result from mistakes in VDJ joining. Science 1985; 229: 1390–3.
   Google Scholar
• Carson DA, Lois A. Cancer progression and p53. Lancet 1995; 346:1009–11.
   PubMed Web of Science ®Google Scholar
• Schwartzman RA, Cidlowski JA. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrinol Rev 1993; 12371–7.
   Google Scholar
• Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R. Determination of the length of the histological stages of
   Google Scholar
• Oberhammer F, Wilson JW, Dive C, et al. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 1993; 12: 3679–84.
   PubMed Web of Science ®Google Scholar
• Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493–501.
   PubMed Web of Science ®Google Scholar
• Gold R, Schmled M, Giegerich G, et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994;71:219–25.
   PubMed Web of Science ®Google Scholar
• Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990; 248: 378–82.
   PubMed Web of Science ®Google Scholar
• Raff MC. Social controls on cell survival and cell death. Nature 1992; 356: 397–403.
   PubMed Web of Science ®Google Scholar
• Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 11928.
   Google Scholar
• Wyllie AH, Rose KA, Morris RG, Steel CM, Foster E, Spandidos DA. Rodent fibroblast tumors expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. Br J Cancer 1987; 56: 251–9.
   PubMed Web of Science ®Google Scholar
• Neiman PE, Thomas SJ, Loring G. Induction of apoptosis during normal and neoplastic B-cell development in the bursa of Fabricius. Proc Natl Acad Sci USA 1991; 88: 5857–61.
   PubMedGoogle Scholar
• Troppmair J, Cleveland JL, Askew DL, Rapp UR. v-Raf/ v-Myc synergism in abrogation of IL-3 dependence: v-Raf suppresses apoptosis. Curr Top Microbiol Immunol 1992; 182: 453–60.
   PubMedGoogle Scholar
• Vogt M, Lesley J, Bogenberger JM, Haggblom C, Swift S, Haas M. The induction of growth factor-independence in murine myelocytes by oncogenes results in monoclonal cell lines and is correlated with cell crisis and karyotypic instability. Oncogene Res 1987; 2: 49–63.
   Google Scholar
• Debbas M, White E. Wild-type p53 mediates apoptosis by E1A which is inhibited by E1B. Genes Dev 1993; 7: 546–54.
   PubMed Web of Science ®Google Scholar
• Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293–9.
   PubMed Web of Science ®Google Scholar
• Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bc1-2 and bax in gene expression in vitro and in vivo. Oncogene 1994; 9: 1799–805.
   PubMed Web of Science ®Google Scholar
• Miyashita T, Harigai M, Hanada R, Reed JC. Identification of a p53-dependent negative response element in the bc1-2 gene. Cancer Res 1994; 54: 3131–5.
   PubMed Web of Science ®Google Scholar
• Aihara M, Truong LD, Dunn JK, Wheller TM, Scardina PT, Thompson TC. Frequency of apoptotic bodies positively correlates with gleason grade in prostate cancer. Hum Pathol 1994; 25: 797–801.
   PubMed Web of Science ®Google Scholar
• Bedi A, Pasricha PJ, Akhtar AJ, et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995; 55:1811–6.
   PubMed Web of Science ®Google Scholar
• Lipponen P, Aaltomaa S, Kosma VM, Syrjänen K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 1994; 30A: 2068–73.
   PubMed Web of Science ®Google Scholar
• Swan DC, Vernon SD, Icenogle JR Cellular proteins involved in papillomavirus-induced transformation. Arch Virol 1994; 138:105–15.
   Google Scholar
• Sheets EE, Crum CP, Yeh J. Association between cervical neoplasia and apoptosis as detected by in situ nuclear labeling. Gynecol Oncol 1996; 63: 94–100.
   PubMed Web of Science ®Google Scholar
• Pan H, Griep AE. Temporarily distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Dev 1995; 9: 2157–69.
   PubMed Web of Science ®Google Scholar
• Kurvinen K, Syrj�nen K, Syrj�nen S. p53 and bcl-2 proteins as prognostic markers in human paplllomavlrus-associated cervical lesions. J Clin Oncol 1996; 14: 2120–30.
   Google Scholar
• Qi-Long L, Abel P, Foster CS, Lalani E. Bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol 1996; 27: 102–10.
   Google Scholar
• Sheets EE, McGahan C, Crum CP, Yeh J. Genetic control of apoptosis during cervical neoplasia. Gynecol Oncol 1996; 62: 417.
   Google Scholar
• Mittal KR, Lin O, Chan W, Goswami S, Demopoulos RI. Cervical squamous dysplasias and carcinomas with �mmunodetectable p53 frequently contain HPV. Gynecol Oncol 1995; 58: 289–94.
   Google Scholar
• Zanetta G, Landoni F, Colombo A, Pellegrino A, Maneo A, Leventis C. Three-year results after neoadjuvant chemotherapy, radical surgery, and radiotherapy in locally advanced cervical carcinoma. Obstet Gynecol 1993; 82: 447–50.
   PubMed Web of Science ®Google Scholar
• Pearcey RG, Stuart GCE, MacLean GD, et al. Phase II study to evaluate the toxicity and efficacy of concurrent cisplatin and radiation therapy in the treatment of patients with locally advanced squamous cell carcinoma of the cervix. Gynecol Oncol 1995; 58: 34–41.
   Web of Science ®Google Scholar
• Erlich E, McCall AR, Potkul RK, Walter S, Vaughan A. Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines. Gynecol Oncol 1996; 60: 251–4.
   Google Scholar
• Kuwashima Y, Uehara T, Kishi K, Shiromizu K, Matsu-zawa M, Takayama S. Proliferative and apoptotic status in endometrial adenocarcinoma. Int J Gynecol Pathol 1995; 14: 45–9.
   Google Scholar
• Heatley MK. Association between the apoptotic index and established prognostic parameters in endometrial adenocarcinoma. Histopathology 1995; 27: 469–72.
   PubMed Web of Science ®Google Scholar
• Jussila T, Stenb�ck F. Cell proliferation markers and growth factors in ovarian cancer. Ann Med 1995; 27: 87–94.
   PubMed Web of Science ®Google Scholar
• McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophos-phamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334: 1–6.
   PubMed Web of Science ®Google Scholar
• Ormerod MG, O'Neill CF, Robertson D, Harrap KR. Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp Cell Res 1994; 211: 231–7.
   PubMed Web of Science ®Google Scholar
• Havrilesky LJ, Elbendary A, Hurteau JA, Whitaker RS, Rodriguez GC, Berchuck A. Chemotherapy-induced apoptosis In epithelial ovarian cancers. Obstet Gynecol 1995; 85: 1007–10.
   PubMed Web of Science ®Google Scholar
• Eliopoulos AG, Kerr DJ, Herod J, et al. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. Oncogene 1995; 11: 1217–23.
   PubMed Web of Science ®Google Scholar
• Perego P, Giarola M, Righetti SC, et al. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Cancer Res 1996; 56: 556–62.
   PubMed Web of Science ®Google Scholar